Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience

Giulia Calabretto; Enrico Attardi; Antonella Teramo; Valentina Trimarco; Samuela Carraro; Sandra Mossuto; Gregorio Barilà; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Monica Crugnola; Pasquale Niscola; Antonella Poloni; Valentina Giai; Valentina Gaidano; Carlo Finelli; Roberta Bertorelle; Cinzia Candiotto; Marco Pizzi; Gianni Binotto; Monica Facco; Fabrizio Vianello; Livio Trentin; Gianpietro Semenzato; Renato Zambello; Valeria Santini

doi:10.1038/s41375-022-01592-3

Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience

Leukemia. 2022 Jul;36(7):1947-1950. doi: 10.1038/s41375-022-01592-3. Epub 2022 May 21.

Authors

Giulia Calabretto^#^{1

2}, Enrico Attardi^#^{3

4}, Antonella Teramo^{1

2}, Valentina Trimarco¹, Samuela Carraro¹, Sandra Mossuto⁴, Gregorio Barilà⁵, Cristina Vicenzetto^{1

2}, Vanessa Rebecca Gasparini^{1

2}, Monica Crugnola^{4

6}, Pasquale Niscola^{4

7}, Antonella Poloni^{4

8}, Valentina Giai^{4

9}, Valentina Gaidano^{4

10}, Carlo Finelli^{4

11}, Roberta Bertorelle¹², Cinzia Candiotto¹², Marco Pizzi¹³, Gianni Binotto^{1

3}, Monica Facco^{1

2}, Fabrizio Vianello¹, Livio Trentin¹, Gianpietro Semenzato^{1

2}, Renato Zambello^#^{14

15

16}, Valeria Santini^#^{17

18}

Affiliations

¹ Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy.
² Veneto Institute of Molecular Medicine (VIMM), Padua, Italy.
³ MDS Unit, Division of Hematology, AOU Careggi-University of Florence, Florence, Italy.
⁴ Italian MDS Foundation (FISIM - ETS), Bologna, Italy.
⁵ Hematology Unit, Ospedale dell'Angelo, Venezia-Mestre, Italy.
⁶ Hematology Unit and BMT Center, AOU-Parma, Parma, Italy.
⁷ Department of Hematology, S. Eugenio Hospital, Rome, Italy.
⁸ Division of Hematology, AOU Ospedali Riuniti - Università Politecnica Marche, Ancona, Italy.
⁹ Division of Hematology, Department of Oncology, AOU Città della Salute e della Scienza, Turin, Italy.
¹⁰ Department of Hematology, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
¹¹ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
¹² Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
¹³ Department of Medicine, Surgical Pathology and Cytopathology Unit, University School of Medicine, Padua, Italy.
¹⁴ Hematology Division, Department of Medicine, Padua University School of Medicine, Padua, Italy. r.zambello@unipd.it.
¹⁵ Veneto Institute of Molecular Medicine (VIMM), Padua, Italy. r.zambello@unipd.it.
¹⁶ Italian MDS Foundation (FISIM - ETS), Bologna, Italy. r.zambello@unipd.it.
¹⁷ MDS Unit, Division of Hematology, AOU Careggi-University of Florence, Florence, Italy. valeria.santini@unifi.it.
¹⁸ Italian MDS Foundation (FISIM - ETS), Bologna, Italy. valeria.santini@unifi.it.

^# Contributed equally.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Bone Marrow
Humans
Myelodysplastic Syndromes*